Industry report: brand TLDs in pharmaceuticals
Pharma companies applied for .brand TLDs to fight counterfeit medicine and phishing. Which ones are active, which went dormant, and what to weigh before the next ICANN round.
Free5 lessons
Course content
-
Brand TLDs in the pharmaceutical sector
- Introduction
-
Portfolio and status
- Pharma brand TLDs and their operators
-
How they are used
- From active to dormant
-
Motivation and context
- Why pharma adopted brand TLDs, and what happened next
-
Towards the next ICANN round
- What pharma brands should weigh for the next round
Sign in or create a free account to follow this course.
Read more in the Academy
-
Brand TLDs in the 2026 Round: the Applicant Guidebook
What a brand TLD is, how the Applicant Guidebook treats it, and the contract obligations that come with running one.
-
ICANN's Next Round of New gTLDs (2026)
Where ICANN's 2026 round of new generic top-level domains stands in October 2026, how the process continues after the application window, and what it means for brand owners.
-
Strategic Use Cases for Brand TLDs
How companies use a brand TLD in practice, from authentication and anti-phishing to internal systems and partner networks, and the legal points that go with each use.